Gritstone Oncology CEO on leveraging cancer drug development for coronavirus vaccine

Name: Gritstone Oncology CEO on leveraging cancer drug development for coronavirus vaccine
Uploaded: 2021-01-21T00:42:48.000Z
Duration: 2 min 10 s
Description: Gritstone Oncology CEO Andrew Allen explained how the nascent cancer drug developer caught the attention of the Gates Foundation in developing a potential coronavirus vaccine to slow the emergence of Covid-19 variants.

Gritstone Oncology CEO Andrew Allen explained how the nascent cancer drug developer caught the attention of the Gates Foundation in developing a potential coronavirus vaccine to slow the emergence of Covid-19 variants.

02:10

Wed, Jan 20 20217:42 PM EST

How Roblox, a video game platform for kids, became a $30 billion company

VIDEO12:38

Apple Car news keeps coming – here's what we know so far

VIDEO13:32

RH tries to become a global luxury brand

VIDEO01:50

FDA advisory panel recommends Johnson & Johnson Covid vaccine

2 hours ago

VIDEO11:49

Cramer's week ahead: The February jobs report will be especially crucial

an hour ago